LumiThera starts enrolling patients for LIGHTSITE II study in Europe to treat AMD
LumiThera, a company developing treatment for ocular diseases, has started enrolling patients for LIGHTSITE II, a multi-center, clinical…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Apr 19
LumiThera, a company developing treatment for ocular diseases, has started enrolling patients for LIGHTSITE II, a multi-center, clinical…
09 Apr 19
Eye care firm Alcon has been separated from Novartis and launched as an independent, publicly traded company to…
08 Apr 19
EyeQue is a device that lets people use their smartphones as part of an at home vision test…
Patient Care DevicesPatient Care MonitoringDiagnostic Devices
03 Apr 19
Lantheus, the parent company of Lantheus Medical Imaging, has collaborated with Cerevast Medical for treating retinal vein occlusion…
27 Mar 19
Johnson & Johnson Vision has announced positive results from two phase 3 clinical studies evaluating investigational antihistamine-releasing contact…
25 Mar 19
Swiss drugmaker Novartis has announced that it is planning to complete the 100% separation of its eye care…
22 Mar 19
Innovative products of Seodong Medical Co., a leading dry eye syndrome treatment devices developer, are gaining significant popularity…
19 Mar 19
Novartis eye care division Alcon has acquired US-based medical device development firm PowerVision in a deal valued at…
13 Mar 19
Glaukos, an ophthalmic medical technology and pharmaceutical company, announced that results of an international glaucoma study published in…
08 Mar 19
A major European medical device company specializing in ophthalmology has signed a three-year agreement to use TrialMaster EDC…